一例通过mNGS揭示潜伏期可能达八年的内脏利什曼病
A Case of Visceral Leishmaniasis with Possible Eight-Year Incubation Period Revealed by Metagenomic Next-Generation Sequencing
DOI: 10.12677/acm.2025.1561697, PDF,   
作者: 田仕君, 杜 阳, 贾 蓓*:重庆医科大学附属第一医院感染科,重庆;夏 红:重庆市大足区人民医院感染科,重庆
关键词: 内脏利什曼病八年潜伏期宏基因组下一代测序Visceral Leishmaniasis Eight-Year Incubation Period Metagenomic Next-Generation Sequencing (mNGS)
摘要: 一名51岁、无基础病患者,因发热2月伴白细胞减少和肝功能异常入院,3次骨髓检查未发现病原体,最终通过血液宏基因组测序技术(mNGS)检测到杜氏利什曼原虫和婴儿利什曼原虫。该患者八年前曾在尼日利亚生活。入院后给予两性霉素B脱氧胆酸盐治疗11天后体温正常,疗程35天两性霉素B脱氧胆酸盐总剂量为1077 mg,尽管在治疗期间出现了心脏轻度增大、持续性白细胞减少、贫血和肌酐升高等不良反应,但他仍顺利完成了治疗,随访9月无复发。
Abstract: A fifty-one-year-old immunocompetent man presented with two-month fever, accompanied by leucopenia and abnormal liver biochemical parameters. Three bone marrow exams did not find parasites and eventually metagenomic next-generation sequencing (mNGS) on blood specimen revealed both Leishmania donovani and Leishmania infantum. He had been working in Nigeria eight years before. His temperature returned to normal after receiving an eleven-day of amphotericin B deoxycholate infusion, and treatment lasting for thirty-five days with a total dosage of 1077 mg. Although he had a cardiomegaly, persistently leucopenia, anemia, creatinine enhancement during treatment, he completed the course with a favorable outcome.
文章引用:田仕君, 夏红, 杜阳, 贾蓓. 一例通过mNGS揭示潜伏期可能达八年的内脏利什曼病[J]. 临床医学进展, 2025, 15(6): 52-56. https://doi.org/10.12677/acm.2025.1561697

参考文献

[1] Aronson, N., Herwaldt, B.L., Libman, M., Pearson, R., Lopez-Velez, R., Weina, P., et al. (2016) Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical Infectious Diseases, 63, e202-e264. [Google Scholar] [CrossRef] [PubMed]
[2] Sundar, S. and Singh, O.P. (2018) Molecular Diagnosis of Visceral Leishmaniasis. Molecular Diagnosis & Therapy, 22, 443-457. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, X., Liu, Y., Zhang, M., Wang, Z., Feng, X., Yang, L., et al. (2022) Case Report: Diagnosis of Visceral Leishmaniasis Using Metagenomic Next-Generation Sequencing and Bone Marrow Smear. Frontiers in Cellular and Infection Microbiology, 12, Article 1095072. [Google Scholar] [CrossRef] [PubMed]
[4] Kone, A.K., Niaré, D.S., Piarroux, M., Izri, A., Marty, P., Laurens, M.B., et al. (2019) Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs. Journal of Parasitology Research, 2019, Article ID: 9282690. [Google Scholar] [CrossRef] [PubMed]
[5] Pederiva, M.M.C., Santos, S.M.D., Rivarola, L.G.S., Guerreiro, V.J., Lopes, K.S., Lima Junior, M.S.D.C., et al. (2023) Asymptomatic Leishmania Infection in Humans: A Systematic Review. Journal of Infection and Public Health, 16, 286-294. [Google Scholar] [CrossRef] [PubMed]
[6] Fletcher, K., Issa, R. and Lockwood, D.N.J. (2015) Visceral Leishmaniasis and Immunocompromise as a Risk Factor for the Development of Visceral Leishmaniasis: A Changing Pattern at the Hospital for Tropical Diseases, London. PLOS ONE, 10, e0121418. [Google Scholar] [CrossRef] [PubMed]
[7] van Griensven, J., Carrillo, E., López-Vélez, R., Lynen, L. and Moreno, J. (2014) Leishmaniasis in Immunosuppressed Individuals. Clinical Microbiology and Infection, 20, 286-299. [Google Scholar] [CrossRef] [PubMed]
[8] Deni, A., De Pascali, A.M., Ortalli, M., Balducelli, E., Provenzano, M., Ferrara, F., et al. (2024) Identification of Asymptomatic Leishmania Infection in Patients Undergoing Kidney Transplant Using Multiple Tests. International Journal of Infectious Diseases, 138, 81-83. [Google Scholar] [CrossRef] [PubMed]
[9] Zheng, C., Wang, L., Li, Y. and Zhou, X. (2020) Visceral Leishmaniasis in Northwest China from 2004 to 2018: A Spatio-Temporal Analysis. Infectious Diseases of Poverty, 9, Article No. 165. [Google Scholar] [CrossRef] [PubMed]
[10] das Chagas, B.D., Pereira, T.M., Cantanhêde, L.M., da Silva, G.P., Boité, M.C., Pereira, L.D.O.R., et al. (2022) Interspecies and Intrastrain Interplay among Leishmania spp. Parasites. Microorganisms, 10, Article 1883. [Google Scholar] [CrossRef] [PubMed]
[11] De Lima Celeste, J.L., Venuto Moura, A.P., França-Silva, J.C., Matos de Sousa, G., Oliveira Silva, S., Norma Melo, M., et al. (2017) Experimental Mixed Infection of Leishmania (Leishmania) amazonensis and Leishmania (L.) infantum in Hamsters (Mesocricetus auratus). Parasitology, 144, 1191-1202. [Google Scholar] [CrossRef] [PubMed]
[12] Antoniou, M., Doulgerakis, C., Pratlong, F., Dedet, J.P. and Tselentis, Y. (2004) Short Report: Treatment Failure Due to Mixed Infection by Different Strains of the Parasite Leishmania infantum. The American Journal of Tropical Medicine and Hygiene, 71, 71-72. [Google Scholar] [CrossRef] [PubMed]
[13] Horrillo, L., Castro, A., Matía, B., Molina, L., García-Martínez, J., Jaqueti, J., et al. (2019) Clinical Aspects of Visceral Leishmaniasis Caused by L. infantum in Adults. Ten Years of Experience of the Largest Outbreak in Europe: What Have We Learned? Parasites & Vectors, 12, Article No. 359. [Google Scholar] [CrossRef] [PubMed]
[14] Chhajed, R., Dahal, P., Singh-Phulgenda, S., Brack, M., Naylor, C., Sundar, S., et al. (2024) Estimating the Proportion of Relapse Following Treatment of Visceral Leishmaniasis: Meta-Analysis Using Infectious Diseases Data Observatory (IDDO) Systematic Review. The Lancet Regional HealthSoutheast Asia, 22, Article ID: 100317. [Google Scholar] [CrossRef] [PubMed]